Sensitive and direct detection of circulating tumor cells by multimarker µ-nuclear magnetic resonance.
about
Click Chemistry-Mediated Nanosensors for Biochemical AssaysMolecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancersEMT, CTCs and CSCs in tumor relapse and drug-resistanceComparison of select cancer biomarkers in human circulating and bulk tumor cells using magnetic nanoparticles and a miniaturized micro-NMR system.Exploring alternative ovarian cancer biomarkers using innovative nanotechnology strategies.Magnetic sensing technology for molecular analysesNanotechnology for the detection and kill of circulating tumor cells.Development of individualized anti-metastasis strategies by engineering nanomedicinesEnhancing reactivity for bioorthogonal pretargeting by unmasking antibody-conjugated trans-cyclooctenes.Miniaturized nuclear magnetic resonance platform for detection and profiling of circulating tumor cellsAscites analysis by a microfluidic chip allows tumor-cell profiling.Rational Design of Materials Interface for Efficient Capture of Circulating Tumor Cells.Cancer subclonal genetic architecture as a key to personalized medicine.Molecular characterization of scant lung tumor cells using iron-oxide nanoparticles and micro-nuclear magnetic resonance.Enrichment, detection and clinical significance of circulating tumor cells.Nanotechnology applications in diagnosis and treatment of metastasis.Recent Developments in Magnetic Diagnostic Systems.Point of care assessment of melanoma tumor signaling and metastatic burden from μNMR analysis of tumor fine needle aspirates and peripheral blood.Highly specific electrochemical analysis of cancer cells using multi-nanoparticle labeling.Highly sensitive detection of cancer cells based on the DNA barcode assay and microcapillary electrophoretic analysis.Materials and microfluidics: enabling the efficient isolation and analysis of circulating tumour cells.Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integrationCirculating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium.
P2860
Q26746175-F784F337-CE2C-4DF3-96A4-8394119D9CB8Q26822406-CBB2FF94-EBD8-42BA-A78E-DFA99BF64DB1Q28082935-F67F0F58-CBE6-4545-B9C5-5309DD7232BCQ30418639-40A08596-7381-4892-8647-C2F892D2FB93Q33810572-D405D12F-C5FF-464D-BD97-8A03673A4424Q33901900-679D1FC3-BB87-4A68-8227-74E84E6C2D92Q34241179-1B111EFB-8FA0-47C7-8161-2AF6CC386BE6Q35967474-51CDC57B-BD4D-435B-AEE0-0BD530C141A4Q37255257-062EF275-0F15-4B2A-B100-907E22520051Q37351130-8EA709DE-A86E-44BE-930E-8A4DC07C9159Q37409535-D4B01394-21EB-4212-9882-4B7819D42568Q37422977-3FF2B7AB-B212-4333-83F7-F2BFC2ED4A8AQ37448116-C56E0BEC-7828-49E0-A538-0722CCCD1335Q37666114-C15D01FB-B78F-4A68-86B2-3542961235C2Q38102590-91C54F74-A108-4DA7-9AF5-BD94706C7A1DQ38254086-00C7AF00-6B47-4CBF-A371-4055FB5279F7Q38563725-F1D05315-EA49-47F0-92BD-B846B7264E40Q38725429-403BB3F9-898B-4E61-A408-817729330877Q38950523-E18B880B-6DD6-44AE-BAC5-C06D555C6D8CQ39016633-2BAC6FF3-C55B-4624-80A6-9413344252FBQ39385781-21FA0882-C9E1-4A65-B396-A4270288BECDQ41879186-C771EFA0-BD84-4C5A-9A5E-3C1256577D89Q47134733-A2AC4573-9D1B-4006-8310-F2358B50085C
P2860
Sensitive and direct detection of circulating tumor cells by multimarker µ-nuclear magnetic resonance.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Sensitive and direct detection ...... µ-nuclear magnetic resonance.
@ast
Sensitive and direct detection ...... µ-nuclear magnetic resonance.
@en
type
label
Sensitive and direct detection ...... µ-nuclear magnetic resonance.
@ast
Sensitive and direct detection ...... µ-nuclear magnetic resonance.
@en
prefLabel
Sensitive and direct detection ...... µ-nuclear magnetic resonance.
@ast
Sensitive and direct detection ...... µ-nuclear magnetic resonance.
@en
P2093
P2860
P356
P1433
P1476
Sensitive and direct detection ...... µ-nuclear magnetic resonance.
@en
P2093
Arezou A Ghazani
Cesar M Castro
Rostic Gorbatov
P2860
P304
P356
10.1596/NEO.12696
P577
2012-05-01T00:00:00Z